Investor directoryForty51 Ventures
Forty51 Ventures is dedicated to building exceptional biotech companies in Europe with a clear path to the clinic.
The facts
- Typical cheque
- €1M – €10M
- Headquarters
- Basel, Switzerland
- Founded
- 2022
Portfolio companies
More portfolio companies
Mosanna TherapeuticsNeuroluna TherapeuticsMysthera TherapeuticsMelodia TherapeuticsCartilla Therapeutics
Questions founders ask
- How much does Forty51 Ventures typically invest?
- Forty51 Ventures states a typical cheque of €1M – €10M.
- Which stages does Forty51 Ventures invest in?
- Forty51 Ventures invests at Seed and Series A.
- Where is Forty51 Ventures based?
- Forty51 Ventures is headquartered in Basel, Switzerland.
Does Forty51 Ventures fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Forty51 Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.